AcouSort AB (publ) (STO:ACOU)
Sweden · Delayed Price · Currency is SEK 4.880
-0.020 (-0.41%)
May 21, 2026, 12:17 PM CET
AcouSort AB Market Cap
AcouSort AB has a market cap or net worth of 103.7 million as of May 21, 2026. Its market cap has increased by 81.31% in one year.
Market Cap
103.70M
Enterprise Value
97.41M
Revenue
10.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.88
Market Cap Chart
Since January 9, 2017, AcouSort AB's market cap has increased from 65.36M to 103.70M, an increase of 58.67%. That is a compound annual growth rate of 5.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 103.70M | 73.14% |
| Dec 30, 2025 | 59.89M | -63.54% |
| Dec 30, 2024 | 164.28M | -29.12% |
| Dec 29, 2023 | 231.76M | 18.13% |
| Dec 30, 2022 | 196.19M | -41.95% |
| Dec 30, 2021 | 337.98M | 24.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 140.70M |
| Simris Group AB (PUBL) | 134.71M |
| NextCell Pharma AB | 121.86M |
| Magle Chemoswed Holding AB | 118.99M |
| IRLAB Therapeutics AB | 106.00M |
| Annexin Pharmaceuticals AB | 105.18M |
| Biovica International AB | 102.17M |
| Scandinavian ChemoTech AB | 92.40M |